Galaxy Health Insurance Appoints Industry Veteran G. Srinivasan as the MD & CEO  

September 9, 2024

India

healthysoch

New Delhi, September 09, 2024:

IRDAI has recently granted license to M/s. Galaxy Health Insurance Co Ltd (formerly known as Galaxy Health & Allied Insurance Co Ltd), to function as a Standalone Health Insurer.  The Company is jointly promoted by Shri. Venu Srinivasan’s renowned industrial giant – TVS group who have joined hands with the family of Shri. V. Jagannathan, former CMD of United India Insurance Co. Ltd and the founder of Star Health & Allied Insurance Co. Ltd.

G. Srinivasan has been appointed as the MD & CEO of the Company. Mr. G. Srinivasan is a prominent figure in the insurance industry and has forty years of experience in various aspects of the Insurance landscape. He has held leadership positions in United India Insurance Co. Ltd., New India Assurance Co. Ltd., and to his credit, it was during his tenure that New India went public. He has been the Director of various Boards including GIC Re.  He was also the Chairman of General Insurance Council and was also the Director of National Insurance Academy, Pune.

The Board currently also comprises of: The Chairman, Dr Sai Satish, a renowned Cardiologist and a pioneer in the field of non-surgical heart valve repair/replacement procedures who has championed heart health and healthy living for almost 3 decades.And Director, Sudarshan Venu, who is currently the Managing Director of TVS Motor Company. He is also the Managing Director of TVS Holdings Ltd, the holding Company and Chairman of TVS Credit Services Limited, the Non-Banking Finance arm of the group.

Stay informed with the latest news from HealthySoch. Sign up today for exclusive insights and updates!

We promise we never spam!

Leave a Reply

Your email address will not be published.

Columnists

HealthySoch

Don't Miss

Annual Conference of Global Association of Physicians of Indian Origin kick-starts in Nagpur

“Over 300 delegates from USA, UK, Australia, Canada, and Middle

WHO strongly recommends Dolutegravir as preferred HIV treatment option

healthysoch Mexico City , July 23, 2019 : Based on